Form 4 for OLMA Olema Pharmaceuticals, Inc.
Accepted 2023-11-22 00:00:00 ET · period of report 2023-11-20 · accession 0001415889-23-015458 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-11-22 | 2023-11-21+ | OLMA | Myles David C. | CH. DISCOV, NON-CLIN DEV OFF | S - Sale | $14.40 | -13.6K | 574.1K | -2% | -$196.2K |
| 2023-11-22 | 2023-11-20 | OLMA | Myles David C. | CH. DISCOV, NON-CLIN DEV OFF | A - Grant | $0.00 | +26.2K | 587.7K | +5% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-11-21 | S | D | 6,776 | $14.87 | 580,952 | D | — | — | (F4) The weighted average sale price for the transaction reported was $14.87, and the range of prices was between $14.26 and $15.25. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. |
| 2 | Common | Common Stock | 2023-11-21 | S | D | 200 | $15.32 | 580,752 | D | — | — | (F5) The weighted average sale price for the transaction reported was $15.32, and the range of prices was between $15.28 and $15.35. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. |
| 3 | Common | Common Stock | 2023-11-20 | A | A | 26,250 | $0.00 | 587,728 | D | — | — | (F1) On November 11, 2022, the Reporting Person was granted certain performance restricted stock units ("PRSUs") for 75,000 shares, which are subject to vesting upon certification by the Compensation Committee of the Company's achieving two different performance milestones. The Compensation Committee certified on November 20, 2023 that 35% of the award vested based upon the certification by the Compensation Committee as to certain performance criteria. (F2) Includes 208 shares acquired under the issuer's Employee Stock Purchase Plan on November 15, 2023. |
| 4 | Common | Common Stock | 2023-11-22 | S | D | 6,653 | $13.89 | 574,099 | D | — | — | (F6) The weighted average sale price for the transaction reported was $13.89, and the range of prices was between $13.62 and $14.15. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. |